Quick Answer
Aardvark Therapeutics, Inc. reported Shares Outstanding of 21.82 million shares for fiscal year 2025.
Aardvark Therapeutics, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 21.82M | +436.4% |
| 2024 | 4.07M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 21.75M | — | +0.2% |
| June 30, 2025 | 21.69M | — | +0.0% |
| March 31, 2025 | 21.69M | — | +433.3% |
| December 31, 2024 | 4.07M | — | — |
- Aardvark Therapeutics, Inc. showed an increase of +436.4% in Shares Outstanding compared to the prior fiscal year.
- Over the 2024–2025 period, Aardvark Therapeutics, Inc.’s shares outstanding has grown by 436.4% (from 4.07 million shares to 21.82 million shares).
- The most recent figure is from Aardvark Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: